COPD Trial, Recruiting NCT07059637 Sponsor: The Cleveland Clinic Condition: COPD
Back to Copd

COPD Trial, Recruiting

NCT07059637
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You were admitted to the hospital mainly because of a COPD flare-up, or you were admitted for serious breathing problems with a COPD flare-up also present.
  • You had a CT scan (a type of detailed X-ray) during your hospital stay, and the scan showed that you have lower than normal muscle mass in your chest area.
  • You are older than 40 years of age.
  • You have been diagnosed with COPD through a breathing test, and your results show at least a moderate level of airflow blockage.
  • You have a smoking history of at least 10 "pack years" (for example, smoking one pack per day for 10 years), and you can be either a current or former smoker.

Who may not be able to join:

  • You have another lung condition in addition to COPD, such as a scarring lung disease or asthma.
  • You are currently being considered for, or are already approved to receive, a lung transplant.
  • You currently have an active cancer diagnosis.
  • You have serious problems with another major organ, such as a weak heart (pumping less than 40% of its normal capacity), kidney failure requiring dialysis, or severe liver scarring (cirrhosis) seen on imaging.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 26 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Amy Attaway, MD, The Cleveland Clinic

Phone: 216-445-2807

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
10 October 2025
Est. completion
1 October 2027

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Mortality; Hospitalizations; Number of COPD exacerbations

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov